Pfizer has ended development of a B7-H4-directed antibody-drug conjugate (ADC), triggering a $1 billion impairment charge. | ...

Zentalis Pharmaceuticals, Inc.’s ZNTL share price has dipped by 21.25%, which has investors questioning if this is right time ...

The goal is to treat various solid tumors, including gynecological cancers such as breast cancer, ovarian cancer, and endometrial cancer ... a Phase 1b dose expansion trial will be conducted.

"Endometrial cancer is diagnosed in the early stages in 80 percent of ... Nouscom is conducting a Phase 1b/2 study on the preventive use of this vaccine in healthy people with Lynch syndrome, an ...

Additionally, we presented the expression patterns of these DEGs across the 32 samples using heatmaps (Figure 1B). In the heatmap ... tumor tissue samples post-radiotherapy for endometrial cancer due ...

Equities research analysts at Wedbush boosted their FY2024 EPS estimates for shares of Zentalis Pharmaceuticals in a research note issued to investors on Wednesday, January 29th. Wedbush analyst R.

Zentalis Pharmaceuticals (NASDAQ:ZNTL – Free Report) had its price target lowered by HC Wainwright from $20.00 to $10.00 in a research report released on Wednesday,Benzinga reports. The firm currently ...

HOUSTON, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize ® liposomal delivery and antisense technology to develop ...

uterine, and head-neck cancers. Patient stratify analysis revealed that NR0B2 expression is a favorite factor in liver cancer patients of Asian males with viral infection history. Correlation analysis ...

Use of long-acting, reversible contraceptives is associated with an increased risk of certain cancers, a study suggests.

The addition of radiation to chemotherapy did not improve overall survival in patients with locally advanced endometrial cancer, a recent phase 3 trial found.

—A new study from California-based researchers reports that things may be getting worse for certain women at risk for endometrial cancer. Here’s what the research team adds to what’s known ...